ResearchGenetic program activity delineates risk, relapse, and therapy responsiveness in multiple myeloma
ResearchMultiple Myeloma DREAM Challenge reveals epigenetic regulator PHF19 as marker of aggressive disease
ResearchBone marrow microenvironments that contribute to patient outcomes in newly diagnosed multiple myeloma: A cohort study of patients in the Total Therapy clinical trials
ResearchPayer decision making for next-generation sequencing-based genetic tests: insights from cell-free DNA prenatal screening